Display options
Share it on

Nutr Metab (Lond). 2006 Jul 19;3:28. doi: 10.1186/1743-7075-3-28.

Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes.

Nutrition & metabolism

Yuchang Fu, Liehong Luo, Nanlan Luo, W Timothy Garvey

Affiliations

  1. Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294-3360, USA. [email protected]

PMID: 16854242 PMCID: PMC1550232 DOI: 10.1186/1743-7075-3-28

Abstract

Resistin is secreted from adipocytes, and high circulating levels have been associated with obesity and insulin resistance. To investigate whether resistin could exert autocrine effects in adipocytes, we expressed resistin gene in 3T3-L1 fibroblasts using a lentiviral vector, and selected several stably-transduced cell lines under blasticidin selection. We observed that 3T3-L1 adipocytes expressing resistin have a decreased gene expression for related transcriptional factors (CCAAT/enhancer binding protein alpha(C/EBPalpha), peroxisome proliferator-activated receptor gamma (PPARgamma), and adipocyte lipid binding protein (ALBP/aP2) which is one of target genes for the PPARgamma during adipocyte differentiation,. Overexpression of resistin increased the levels of three proinflammatory cytokines, tumor necrosis factor alpha (TNFalpha), interleukin 6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1), which play important roles for insulin resistance, glucose and lipid metabolisms during adipogenesis. Furthermore, overexpressing resistin in adipocytes inhibits glucose transport 4 (GLUT4) activity and its gene expression, reducing insulin's ability for glucose uptake by 30%. In conclusion, resistin overexpression in stably transduced 3T3-L1 cells resulted in: 1) Attenuation of programmed gene expression responsible for adipogenesis; 2) Increase in expression of proinflammatory cytokines; 3) Decrease in insulin responsiveness of the glucose transport system. These data suggest a new role for resistin as an autocrine/paracrine factor affecting inflammation and insulin sensitivity in adipose tissue.

References

  1. J Lipid Res. 2005 Jul;46(7):1369-79 - PubMed
  2. J Biol Chem. 1985 Mar 10;260(5):2646-52 - PubMed
  3. J Clin Invest. 2004 Jul;114(2):224-31 - PubMed
  4. Science. 2004 Feb 20;303(5661):1195-8 - PubMed
  5. Diabetes. 1992 Mar;41(3):274-85 - PubMed
  6. Genes Dev. 2000 Jun 1;14(11):1293-307 - PubMed
  7. Med Sci Monit. 2003 Feb;9(2):RA55-61 - PubMed
  8. Genes Dev. 1994 May 15;8(10):1224-34 - PubMed
  9. J Biol Chem. 1997 Aug 22;272(34):21473-8 - PubMed
  10. Semin Cell Dev Biol. 1999 Feb;10(1):19-29 - PubMed
  11. Cell. 1976 Jan;7(1):105-13 - PubMed
  12. Mol Cell. 1999 Oct;4(4):611-7 - PubMed
  13. J Clin Endocrinol Metab. 2003 Mar;88(3):1055-8 - PubMed
  14. Diabetes Metab. 2004 Feb;30(1):13-9 - PubMed
  15. Curr Opin Lipidol. 2002 Feb;13(1):51-9 - PubMed
  16. J Biol Chem. 2003 Nov 14;278(46):45209-15 - PubMed
  17. Diabetes. 2004 Jul;53(7):1671-9 - PubMed
  18. Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E106-15 - PubMed
  19. J Biol Chem. 2001 Apr 6;276(14):11252-6 - PubMed
  20. J Biol Chem. 1993 Apr 5;268(10):6823-6 - PubMed
  21. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):502-6 - PubMed
  22. J Biol Chem. 1999 Jun 11;274(24):17088-97 - PubMed
  23. Cell. 1975 May;5(1):19-27 - PubMed
  24. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70 - PubMed
  25. Nature. 2001 Jan 18;409(6818):307-12 - PubMed
  26. J Clin Invest. 2003 Jan;111(2):225-30 - PubMed

Publication Types

Grant support